Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5340-5350

  Fluur, Caroline ^a   De Milito, Angelo ^b   Fry, Terry J ^c   Vivar, Nancy ^a   Eidsmo, Liv ^a   Atlas, Ann ^d   Federici, Cristina ^b   Matarrese, Paola ^b   Logozzi, Mariantonia ^b   Rajnavölgyi, Eva ^e   Mackall, Crystal L ^c   Fais, Stefeno ^b   Chiodi, Francesca ^a   Rethi, Bence ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; FAS ANTIGEN; INTERLEUKIN 7;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOSKELETON; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTOPENIA; MACACA; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; T LYMPHOCYTE; UPREGULATION;

EID: 34247156743     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5340     Document Type: Article

References (53)

1. Krueger, A., S. C. Fas, S. Baumann, and P. H. Krammer. 2003. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 193: 58-69.
2. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5: 625-630.
3. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158: 4602-4611.
4. Muppidi, J. R., and R. M. Siegel. 2004. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 5: 182-189.
5. Parlato, S., A. M. Giammarioli, M. Logozzi, F. Lozupone, P. Matarrese, F. Luciani, M. Falchi, W. Malorni, and S. Fais. 2000. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19: 5123-5134.
6. Fais, S., A. De Milito, and F. Lozupone. 2005. The role of FAS to ezrin association in FAS-mediated apoptosis. Apoptosis 10: 941-947.
7. Refaeli, Y., L. Van Parijs, C. A. London, J. Tschopp, and A. K. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8: 615-623.
8. Silvestris, F., P. Cafforio, M. A. Frassanito, M. Tucci, A. Romito, S. Nagata, and F. Dammacco. 1996. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS 10: 131-141.
9. Baumler, C. B., T. Bohler, I. Herr, A, Benner, P. H. Krammer, and K. M. Debatin. 1996. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 88: 1741-1746.
10. + T lymphocytes during HIV infection. J. Immunol. 156: 2282-2293.
11. Grelli, S., S. Campagna, M. Lichtner, G. Ricci, S. Vella, V. Vullo, F. Montella, S. Di Fabio, C. Favalli, A. Mastino, and B. Macchi. 2000. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy. AIDS 14: 939-949.
12. + T cells. Nature 434: 1148-1152.
13. + T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 87: 581-585.
14. Hosaka, N., N. Oyaizu, S. Than, and S. Pahwa. 2000. Correlation of loss of CD4 T cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants. Clin. Immunol. 95: 20-25.
15. Katsikis, P. D., E. S. Wunderlich, C. A. Smith, and L. A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036.
16. Badley, A. D., A. A. Pilon, A, Landay, and D. H. Lynch. 2000. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96: 2951-2964.
17. Gougeon, M. L. 2003. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3: 392-404.
18. Brugnoni, D., P. Airo, M. Pennacchio, G. Carella, A. Malagoli, A. G. Ugazio, F. Porta, and R. Cattaneo. 1999. Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death. Bone Marrow Transplant. 23: 451-457.
19. Hakim, F. T., R. Cepeda, S. Kaimei, C. L. Mackall, N. McAtee, J. Zujewski, K. Cowan, and R. E. Gress. 1997. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90: 3789-3798.
20. Fry, T. J., B. L. Christensen, K. L. Komschlies, R. E. Gress, and C. L. Mackall. 2001. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 97: 1525-1533.
21. Jiang, Q., W. Q. Li, F. B. Aiello, R. Mazzucchelli, B. Asefa, A. R. Khaled, and S. K. Durum. 2005. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. 16: 513-533.
22. Fry, T. J., and C. L. Mackall. 2001. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 22: 564-571.
23. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
24. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737.
25. Kondrack, R. M., J. Harbertson, J. T. Tan, M. E. McBreen, C. D. Surh, and L. M. Bradley. 2003. Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 198: 1797-1806.
26. Gringhuis, S. I., L. F. de Leij, E. W. Verschuren, P. Borger, and E. Vellenga. 1997. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood 90: 2690-2700.
27. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
28. Li, J., G. Huston, and S. L. Swain. 2003. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J. Exp. Med. 198: 1807-1815.
29. Napolitano, L. A., R. M. Grant, S. G. Decks, D. Schmidt, S. C. De Rosa, L. A. Herzenberg, B. G. Herndier, J. Andersson, and J. M. McCune. 2001. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7: 73-79.
30. Fry, T. J., E. Connick, J. Falloon, M. M. Lederman, D. J. Liewehr, J. Spritzler, S. M. Steinberg, L. V. Wood, R. Yarchoan, J. Zuckerman, et al. 2001. A potential role for interleukin-7 in T-cell homeostasis. Blood 97: 2983-2990.
31. Llano, A., J. Barretina, A. Gutiérrez, J. Blanco, C. Cabrera, B. Clotet, and J. A. Esté. 2001. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J. Virol. 75: 10319-10325.
32. Mastroianni, C. M., G. Forcina, G. d'Ettorre, M. Lichtner, F. Mengoni, C. D'Agostino, and V. Vullo. 2001. Circulating levels of interleukin-7 in antiretroviral-naive and highly active antiretroviral therapy-treated HIV-infected patients. HIV Clin. Trials 2: 108-112.
33. Bolotin, E., G. Annett, R. Parkman, and K. Weinberg. 1999. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant. 23: 783-788.
34. + T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J. Immunol. 171: 61-68.
35. Managua, E. Z., A. Landay, and L. Al-Harthi. 2005. Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells. Immunology 114: 322-335.
36. Lelievre, J. D., F. Petit, D. Arnoult, J. C. Ameisen, and J. Estaquier. 2005. Interleukin 7 increases human immunodeficiency virus type 1 LAI-mediated Fas-induced T-cell death. J. Virol. 79: 3195-3199.
37. + regulatory T cells. Nat. Med. 11: 1238-1243.
38. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, et al. 2003. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101: 2294-2299.
39. Riemann, D., A. Tcherkes, G. H. Hansen, J. Wulfaenger, T. Blosz, and E. M. Danielsen. 2005. Functional co-localization of monocytic aminopeptidase N/CD13 with the Fcγ receptors CD32 and CD64. Biochem. Biophys. Res. Commun. 331: 1408-1412.
40. -ΔΔCT method. Methods 25: 402-408.
41. Lozupone, F., L. Lugini, P. Matarrese, F. Luciani, C. Federici, E. Iessi, P. Margutti, G. Stassi, W. Malorni, and S. Fais. 2004. Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. J. Biol. Chem. 279: 9199-9207.
42. Fais, S., and W. Malomi. 2003. Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions. J. Leukocyte Biol. 73: 556-563.
43. Rethi, B., C. Fluur, A. Atlas, M. Krzyzowska, F. Mowafi, S. Grutzmeier, A. De Milito, R. Bellocco, K. I. Falk, E. Rajnavölgyi, and F. Chiodi. 2005. Loss of IL-7Rα is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 19: 2077-2086.
44. + T cells in HIV-infected individuals. J. Immunol. 174: 2900-2909.
45. Boutboul, F., D. Puthier, V. Appay, O. Pelle, H. Ait-Mohand, B. Combadiere, G. Carcelain, C. Katlama, S. L. Rowland-Jones, P. Debre, et al. 2005. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 19: 1981-1986.
46. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576.
47. + T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 87: 4959-4966.
48. Kimura, K., H. Matsubara, S. Sogoh, Y. Kita, T. Sakata, Y. Nishitani, S. Watanabe, T. Hamaoka, and H. Fujiwara. 1991. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. J. Immunol. 146: 2618-2624.
49. Borghesi, L. A., Y. Yamashita, and P. W. Kincade. 1999. Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. Blood 93: 140-148.
50. Banwell, C. M., K. M. Partington, E. J. Jenkinson, and G. Anderson. 2000. Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development. Eur. J. Immunol. 30: 2125-2129.
51. Ahmad, R., S. T. Sindhu, E. Toma, R. Morisset, and A. Ahmad. 2003. Studies on the production of IL-15 in HIV-infected/AIDS patients. J. Clin. Immunol. 23: 81-90.
52. Dockrell, D. H. 2003. The multiple roles of Fas ligand in the pathogenesis of infectious diseases. Clin. Microbiol. Infect. 9: 766-779.
53. + T lymphocytes. Cell Death Differ. 11: 574-582.